George Millen: Unscripted

The NHL's new multiyear deal with Athletic Brewing isn't just about wellness. It's a calculated financial strategy to unbundle legacy alcohol sponsorships.

Trupanion has tapped Simon Cowell to crack the 95% of North American pets without insurance. But can celebrity trust mask the reality of rising premiums?

VAALCO Energy completes its Gabon drilling and pivots to Côte d'Ivoire, securing cash flows and setting the stage for a major 2027 production inflection.

Sultan Ahmed Alimirah’s urgent plea for peace in the Afar homeland exposes the fragile intersection of human tragedy and global supply chain vulnerability.

Centalion Group’s acquisition of Silver Hill's Haynesville assets reveals a massive shift: commodity traders are now drilling for their own LNG feedstock.

As AI agents gain unprecedented access to corporate data, Bedrock Data’s DBOM technology is shifting the security focus from hackers to internal governance.

Dr. Andrey Tyuftin's nomination for a global sustainability award reveals how ocean sand could finally make compostable packaging economically viable.

MHC Software secures a Major Player spot in the 2026 IDC MarketScape, proving that proactive compliance and governed AI are the new enterprise mandates.

As One Inc secures its spot on the 2026 InsurTech100, George Millen explores why purpose-built payment rails are quietly dominating the P&C insurance sector.

As liver cancer deaths near 31,000 annually, a new House resolution and AI-driven blood tests aim to fix a broken screening system for high-risk patients.

Benchmark Energy's $47.5M financing from Cibolo highlights a shift: traditional banks are out, and alternative debt is fueling a disciplined upstream revival.

Tempo's new MCP Server allows PMOs to query budget and capacity data via AI, fundamentally altering how enterprise resources are tracked and managed.

The 2026 Nobel Prize in Medicine honors three scientists who turned light into a neurological remote control, paving the way for revolutionary clinical therapies.

Pacira BioSciences taps Molteni Farmaceutici to navigate Europe’s fragmented market, trading direct control for a capital-efficient rollout of EXPAREL.

New clinical data published in the Journal of Fungi reveals Moberg Pharma's MOB-015 overcomes terbinafine resistance, unlocking massive market potential.

A private facial recognition firm just helped locate 34 missing youth in New York, spotlighting the complex trade-off between civil liberties and public safety.

Johnson & Johnson’s new eye health campaign highlights a hidden menopause symptom, revealing a calculated push to capture a booming demographic market.

EY’s new alliance with AI startup Aaru replaces months of traditional market research with synthetic human simulations, reshaping high-stakes corporate strategy.

As artificial intelligence moves from the cloud to the factory floor, South Korean conglomerates are leveraging robotics to secure American industrial clout.

Missouri's new partnership with Impruvon isn't just a software upgrade—it's a calculated move to salvage a collapsing caregiving workforce.